Compare boswellia products by the active the label states and the daily dose, not by price per bottle. Of five products read in October 2026, only Life Extension (AprèsFlex, 20% AKBA) and Swanson (5-LOXIN, 30% AKBA) print an AKBA figure; at their label doses they deliver 20 mg and 75 mg of AKBA a day for $0.28 and $0.83. NOW (65% organic acids), Doctor's Best (40% boswellic acids) and Thorne (a phytosome) state other measures. Boswellia is studied in people with osteoarthritis; no product here is approved to treat any disease, and NIH's NCCIH says there is not enough high-quality evidence to judge whether it is useful for any condition.
Choosing a boswellia supplement, in five decisions:
- Find the active the label prints. AKBA (5-LOXIN, AprèsFlex) or total boswellic or organic acids (NOW, Doctor's Best) are different measures; a phytosome may print neither.
- Multiply by your real dose. Extract mg a day times the label percentage is the active you receive, and Swanson's serving is one capsule although its directions say two a day.
- Match the trial. 5-LOXIN was studied at 100 mg and 250 mg a day for 90 days in people with knee osteoarthritis; a different extract has a different evidence base.
- Check who was studied. The trials enrolled people with osteoarthritis, so they describe that group and are not a promise for healthy joints.
- Read NCCIH first. It says little is known about medicinal amounts in pregnancy and breastfeeding and advises talking to a provider if you take medicine.
Label dose matches a trial arm: Swanson Ultra 5-LOXIN, 250 mg a day, 30% AKBA, $0.83 a day.
Most total acids per softgel: NOW Boswellia Extract 500 mg, at least 65% organic acids, $0.33 a softgel (October 19 read).
Phytosome: Thorne Boswellia Phytosome, 350 mg, $0.98 a day.
How we compiled this · not medical advice. We read each product's label facts, price and stated certifications on the brand's own product page (dates beside each figure), read the trials in their PubMed abstracts and NIH's NCCIH page, and graded the ingredient with our published A to D rubric. We did not buy or lab-test these products. Price per day is list price divided by days of supply at the label dose. Some links are affiliate links; they never change the ranking.
What AKBA is and why labels standardize to it
Boswellia supplements come from the gum resin of Boswellia serrata, the Indian frankincense tree. The resin contains boswellic acids, and one of them, 3-O-acetyl-11-keto-beta-boswellic acid (AKBA), is the one several branded extracts are standardized to. Swanson's label reads "5-LOXIN Boswellia serrata Extract [standardized to 30% acetyl-11-keto-beta boswellic acid (AKBA) (gum resin)] 125 mg", and Life Extension's reads "AprèsFlex (Boswellia serrata) extract (gum resin) [std. to 20% 3-O-acetyl-11-keto-beta-boswellic acid (AKBA)] 100 mg". Both are the numbers you can multiply.
The other three products are standardized differently or not at all. NOW's softgel states "min. 65% Organic Acids including Boswellic Acid" for 500 mg. Doctor's Best states 40% boswellic acids for 500 mg of extract, in a two-capsule serving that also contains 40 mg of UC-II undenatured type II collagen, which this page does not review. Thorne's capsule contains 350 mg of an "Indian Frankincense Phytosome (Phospholipid complex from Sunflower)" with no percentage. Our boswellia guide covers the 5-lipoxygenase mechanism and the evidence in more depth; this page is the buying decision.
Branded extracts: 5-LOXIN, AprèsFlex, phytosome and generic
5-LOXIN, from the Sengupta group's trials, is the extract with the clearest human record on this list: the 2008 trial gave 100 mg or 250 mg a day, or placebo, for 90 days to people with knee osteoarthritis and reported lower pain and function scores, and the 2010 comparison gave 100 mg a day of 5-LOXIN or of Aflapin against placebo. A 2011 laboratory and animal paper reported that Aflapin raised AKBA availability in the circulation of experimental animals by 51.78% compared with a 30% AKBA extract, which is preclinical, not yet confirmed in humans.
AprèsFlex is a trademark of PLT Health Solutions-Laila Nutraceuticals per Life Extension's label, and its page says it "absorbs into the blood 52% more than previously available boswellia extracts". Our boswellia guide treats AprèsFlex as the same ingredient as Aflapin; Life Extension's page does not mention Aflapin, and we did not find a trial naming AprèsFlex in the abstracts read for this page, so we treat the link to the 2010 Aflapin arm as unconfirmed. Thorne's page names Casperome as the trade name of its boswellia phytosome, boswellia extract "chemically bound to phospholipids to increase its absorption". The generic products, NOW and Doctor's Best, have no named-extract trial to point to.
- AKBA, labeled (30% and 20%)
- total boswellic or organic acids (AKBA not stated)
- rest of the extract
Comparison table: extract, standardization, dose and price per day
Life Extension is the cheapest day at $0.28, NOW the cheapest per softgel at $0.33, and Thorne the dearest at $0.98. Every price is the one-time list price, with exceptions marked.
| Product | Extract | Standardization | Dose × capsules a day | List price / count | Per day | Certification |
|---|---|---|---|---|---|---|
| 5-LOX Inhibitor with AprèsFlex | AprèsFlex | 20% AKBA | 100 mg × 1 | $16.50 / 60 | $0.28 | none on page |
 Swanson Ultra 5-LOXIN | 5-LOXIN | 30% AKBA | 125 mg × 2 | $24.79 / 60 caps | $0.83 | none on page |
| NOW Boswellia Extract 500 mg | standardized gum resin extract | min 65% organic acids | 500 mg × 1 | $29.99 / 90 † | $0.33 | GMP facility seal only |
 Doctor's Best Boswellia + UC-II | gum resin extract + 40 mg UC-II | 40% boswellic acids | 500 mg × 1 (2 caps) | $21.99 / 30 † | $0.73 | none on page |
| phytosome (Casperome) | no % stated | 350 mg × 1 | $59.00 / 60 | $0.98 | none on page |
† NOW's and Doctor's Best's pages returned access-denied or rate-limit responses on October 26, 2026; the figures are from the October 19 read ($29.99 for 90 softgels, 500 mg each, "Take 1 softgel 1 to 2 times daily"; $21.99 for 60 capsules, serving two capsules, 30 servings). NOW at two softgels a day would cost $0.67. Swanson's one-time price is $24.79 ($0.41 a capsule), or $0.25 a serving on its 40%-off subscription price. Our boswellia guide lists NOW at about $14 and Doctor's Best (a different 250 mg product) at about $12; the figures above are the newer reads for these specific products.
The picks, by what each does best
Swanson Ultra 5-LOXIN Boswellia Serrata ExtractDoctor's Best Boswellia + UC-II- stated or matched
- plausible but unconfirmed link
- not found
What the clinical trials studied, and in whom
- Yu et al., 2020 (PMID 32680575): a systematic review and meta-analysis of seven randomized trials with 545 people with osteoarthritis, reporting lower VAS pain, WOMAC pain, stiffness and function scores and Lequesne index than control, and recommending at least 4 weeks of treatment. It describes who was studied; the authors' conclusion is theirs, not ours.
- Sengupta et al., 2008 (PMID 18667054): 75 people with knee osteoarthritis given 100 mg or 250 mg of 5-LOXIN (30% AKBA) daily or placebo for 90 days; both doses improved pain and function scores, with 70 completing.
- Sengupta et al., 2010 (PMID 21060724): 60 subjects given 100 mg a day of 5-LOXIN or Aflapin, or placebo, for 90 days; both improved pain and function scores, and the authors reported Aflapin was better.
- NCCIH (updated April 2025): "Several studies have shown taking boswellia orally may help reduce inflammation and pain associated with osteoarthritis," while its key point is that there is "not enough high-quality evidence to determine whether boswellia is useful for any health condition".
These are small studies of specific extracts in a disease population. They are why the page speaks of joint comfort studied in people with osteoarthritis, and never of any product relieving or treating arthritis.
Which boswellia should you buy? A verdict for each kind of reader
- Wants the cheapest day
Life Extension AprèsFlex at $0.28, one capsule, with the lowest AKBA load (20 mg).
- Wants a label that matches a trial arm
Swanson 5-LOXIN, two 125 mg capsules a day (250 mg, the high arm of the 2008 trial), $0.83 a day.
- Wants the most total acids for the money
NOW 500 mg, at least 325 mg of organic acids per softgel for $0.33; no AKBA figure and no named trial.
- Wants the absorption-designed form
Thorne phytosome at $0.98 a day, accepting no stated percentage.
- Drug-tested athlete
None of the five shows an NSF, USP or Informed Sport listing on its page. Ask for a lot certificate first.
- Pregnant, breastfeeding, or on medication
Ask a provider first. NCCIH says little is known about medicinal amounts in pregnancy and breastfeeding, and advises talking to a provider about herbs if you take medicine.
- Has diagnosed arthritis or joint pain
See a clinician for assessment. The trials describe people with osteoarthritis under care; a supplement is not a substitute for it.
Copy this extract check before you buy
The boswellia extract check below turns each label into the active you actually take. Copy it into your notes app.
BOSWELLIA EXTRACT CHECK 1. Extract named (5-LOXIN / AprèsFlex / Aflapin / phytosome / generic): ________ 2. Extract per capsule: ____ mg Capsules a day on the label: ____ Daily mg: ____ 3. Standardized active printed (AKBA % or total boswellic/organic acids %): ____ % Note: AKBA and total acids are different measures. 4. Daily active (2 x 3 / 100): ____ mg 5. Bottle price $____ / days of supply ____ = $____ a day 6. Cost per 100 mg of active (5 / 4 x 100): $____ 7. Trial for this named extract at my daily dose? (5-LOXIN: 100 and 250 mg a day, 90 days): Y / N 8. Contents seal in the certifier's own database (NSF, USP, Informed Sport)? ________ 9. Pregnant, breastfeeding, on medication, or has diagnosed arthritis? Ask a clinician first. Y / N Source: NIH NCCIH boswellia (updated April 2025); PubMed 18667054, 21060724, 32680575.
What the evidence grade covers, and what it does not
Evidence grade
Grade B in people with osteoarthritis, not a general benefit claim (ring: B is the third step of A to D).
Patients pooled
Yu 2020 meta-analysis (ring: share of 1,000 patients).
Longest 5-LOXIN trial
Sengupta 2008 and 2010 (ring: share of a year).
Grade B means several randomized trials show positive results, but with smaller samples or fewer replications, and that is what a seven-trial, 545-patient meta-analysis in osteoarthritis amounts to. The grade is for that population and those outcomes. NCCIH's own summary is more cautious, which is why the grade stops at B and why this page makes no claim that boswellia treats arthritis. The same grade is entered in our evidence dashboard in the same release so the two cannot disagree. For the surrounding routines, see the Anti-Inflammatory Stack, best turmeric and curcumin and our curcumin deep dive.
Who should not take boswellia without medical advice
NCCIH says boswellia is likely safe orally and that extract up to 1,000 mg daily has been used safely in several trials of up to 6 months, but that little is known about oral medicinal amounts in pregnancy and breastfeeding. It advises talking with a health care provider before using herbal products, especially if you take medicine. Thorne's page states the product is contraindicated for anyone with a history of hypersensitivity to any ingredient, and Doctor's Best says its product is not recommended for children or for pregnant or lactating individuals.
If you have joint pain, a supplement is not the first step: get it assessed. See also NCCIH on using dietary supplements wisely, and remember the FDA does not approve dietary supplements before they are marketed.
Frequently asked questions
What is AKBA on a boswellia label? AKBA is 3-O-acetyl-11-keto-beta-boswellic acid, one of the boswellic acids in Boswellia serrata gum resin and the one that 5-LOXIN and AprèsFlex labels standardize to (30% and 20% respectively). Other products, such as NOW's, state a share of total boswellic or organic acids (65%) without an AKBA figure, so the percentages measure different things and cannot be compared directly.
Is boswellia proven for arthritis? No product here is approved to treat a disease. A 2020 systematic review and meta-analysis pooled seven randomized trials with 545 people with osteoarthritis and reported lower pain, stiffness and function scores than control (Yu et al., PMID 32680575), but NIH's NCCIH, updated April 2025, says there is not enough high-quality evidence to determine whether boswellia is useful for any health condition. We describe who was studied and draw no treatment claim.
What dose do boswellia trials use? The 5-LOXIN trial (Sengupta et al. 2008) gave 100 mg or 250 mg a day for 90 days to people with knee osteoarthritis, and a 2010 trial compared 100 mg a day of 5-LOXIN with 100 mg a day of Aflapin against placebo. NCCIH says extract at up to 1,000 mg a day has been used safely in several trials of up to 6 months. A label dose is therefore often one of the trialed arms, but only for the named extract.
Is boswellia safe? NCCIH says boswellia is likely to be safe when taken orally. It adds that little is known about its safety in medicinal amounts during pregnancy and breastfeeding, and advises talking to a health care provider before using herbal products, especially if you take medicine. Thorne's page tells pregnant users to consult a practitioner, and Doctor's Best says its product is not recommended for children or for pregnant or lactating individuals.
Is any boswellia product here third-party certified? None of the five product pages shows a contents certification from NSF, USP or Informed Sport (read October 2026). NOW shows a GMP facility seal on its site, which certifies manufacturing practice, not the contents of this product. If you are drug-tested in sport or want a certificate, ask the brand for one for your lot.
How long until boswellia has been studied to work? The Yu meta-analysis recommended at least 4 weeks of treatment, and the 5-LOXIN trials ran 90 days. Those are the durations people with osteoarthritis were studied for; they say nothing about healthy joints, and none of this is a promise for any product.
Bottom line
Pick the label you can check. Swanson's 5-LOXIN is the product whose daily dose matches a trial arm and the lowest cost per milligram of AKBA ($0.83 a day for 75 mg), Life Extension's AprèsFlex is the cheapest day ($0.28) with a lighter 20 mg AKBA load, and NOW, Doctor's Best and Thorne state other measures or none. All trials describe people with osteoarthritis, NCCIH says the evidence is not yet high quality, and no product here is approved to treat a disease.
Method and sources
Product facts and prices were read on each brand's own product page (Life Extension, Swanson and Thorne on October 26, 2026; NOW and Doctor's Best on October 19, 2026, as marked, because they returned access-denied or rate-limit responses on October 26). Cost per day is list price divided by days of supply at the label directions; AKBA milligrams are daily extract milligrams multiplied by the label percentage. NOW's 325 mg is a floor from "min. 65%". We did not purchase or lab-test any product. Review cadence: this page is re-checked when a listed product changes its price, extract or label, or NCCIH revises its boswellia page.
- NIH NCCIH, Boswellia: Usefulness and Safety, last updated April 2025.
- Yu G et al., BMC Complement Med Ther 2020;20(1):225, PMID 32680575.
- Sengupta K et al., Arthritis Res Ther 2008;10(4):R85, PMID 18667054.
- Sengupta K et al., Int J Med Sci 2010;7(6):366-377, PMID 21060724.
- Sengupta K et al., Mol Cell Biochem 2011;354:189-197, PMID 21479939 (preclinical).
- NIH NCCIH, Using Dietary Supplements Wisely.
- US FDA, Questions and Answers on Dietary Supplements.
- Brand pages: Life Extension, Swanson, NOW, Doctor's Best, Thorne.
Get the independent testing digest
The third-party lab results, certification-database checks and safety alerts behind our rankings. We have not started sending yet; we will only email when we do.